For the first time, researchers have created human antibodies that could neutralize the venom of European black widow spiders.
The new human antibodies could transform the way we treat spider bites, reducing the need for traditional antivenom derived from horses.
The venom of these spiders could lead to serious nervous system complications. “The human antibodies were selected from our human naive antibody gene libraries HAL9/10 by phage display. Phage display is an in vitro technology to generate antibodies,” Hust explained.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Crowned | POPSUGARStories that center Black experiences, amplify Black voices, and celebrate Black joy.
Lire la suite »
New experimental black widow venom antidote uses human antibodiesLaura is a science news writer, covering a wide variety of subjects, but she is particularly fascinated by all things aquatic, paleontology, nanotechnology, and exploring how science influences daily life. Laura is a proud former resident of the New Jersey shore, a competitive swimmer, and a fierce defender of the Oxford comma.
Lire la suite »
When It Comes to the Green Transition, Can Human Intelligence Beat Human Greed?Bill McKibben is the Schumann Distinguished Scholar at Middlebury College and co-founder of 350.org and ThirdAct.org. His most recent book is 'Falter: Has the Human Game Begun to Play Itself Out?.
Lire la suite »
European stocks slump after European vote, shock French electionEuropean stocks slump after European vote, shock French election
Lire la suite »
European stocks lose steam after European Central Bank cutEuropean stocks moved lower on Friday, after closing at a record high during the previous session.
Lire la suite »
European stocks open marginally higher after European Central Bank cutEuropean stocks opened slightly higher on Friday, after closing at a record high during the previous session.
Lire la suite »